Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of USANA HEALTH SCIENCES INC from 28 Dec 2019 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
USANA HEALTH SCIENCES INC quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 28 Dec 2019 to 27 Sep 2025.
  • USANA HEALTH SCIENCES INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 27 Sep 2025 was $1,794,000, a 90% decline year-over-year.
  • USANA HEALTH SCIENCES INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 27 Sep 2025 was $47,779,000, a 48% decline year-over-year.
  • USANA HEALTH SCIENCES INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $76,351,000, a 25% decline from 2023.
  • USANA HEALTH SCIENCES INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $102,453,000, a 5.7% decline from 2022.
  • USANA HEALTH SCIENCES INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $108,621,000, a 36% decline from 2021.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

USANA HEALTH SCIENCES INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $47,779,000 $1,794,000 -$16,814,000 -90% 29 Jun 2025 27 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $64,593,000 $18,817,000 -$1,386,000 -6.9% 30 Mar 2025 28 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $65,979,000 $16,739,000 -$10,372,000 -38% 29 Dec 2024 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $76,351,000 $10,429,000 -$16,182,000 -61% 29 Sep 2024 28 Dec 2024 10-K 12 Mar 2025 2023 FY
Q3 2024 $92,533,000 $18,608,000 -$1,923,000 -9.4% 30 Jun 2024 28 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $94,456,000 $20,203,000 -$6,607,000 -25% 31 Mar 2024 29 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $101,063,000 $27,111,000 -$1,390,000 -4.9% 31 Dec 2023 30 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $102,453,000 $26,611,000 +$3,809,000 +17% 01 Oct 2023 30 Dec 2023 10-K 12 Mar 2025 2023 FY
Q3 2023 $98,644,000 $20,531,000 -$2,693,000 -12% 02 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $101,337,000 $26,810,000 -$2,498,000 -8.5% 02 Apr 2023 01 Jul 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $103,835,000 $28,501,000 -$4,786,000 -14% 01 Jan 2023 01 Apr 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $108,621,000 $22,802,000 -$8,844,000 -28% 02 Oct 2022 31 Dec 2022 10-K 12 Mar 2025 2023 FY
Q3 2022 $117,465,000 $23,224,000 -$17,126,000 -42% 03 Jul 2022 01 Oct 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $134,591,000 $29,308,000 -$25,002,000 -46% 03 Apr 2022 02 Jul 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $159,593,000 $33,287,000 -$11,049,000 -25% 02 Jan 2022 02 Apr 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $170,642,000 $31,646,000 03 Oct 2021 01 Jan 2022 10-K 27 Feb 2024 2023 FY
Q3 2021 $40,350,000 -$3,925,000 -8.9% 04 Jul 2021 02 Oct 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $54,310,000 04 Apr 2021 03 Jul 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $44,336,000 03 Jan 2021 03 Apr 2021 10-Q 11 May 2022 2022 Q1
Q3 2020 $44,275,000 28 Jun 2020 26 Sep 2020 10-Q 10 Nov 2021 2022 Q3

USANA HEALTH SCIENCES INC Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $76,351,000 -$26,102,000 -25% 31 Dec 2023 28 Dec 2024 10-K 12 Mar 2025 2023 FY
2023 $102,453,000 -$6,168,000 -5.7% 01 Jan 2023 30 Dec 2023 10-K 12 Mar 2025 2023 FY
2022 $108,621,000 -$62,021,000 -36% 02 Jan 2022 31 Dec 2022 10-K 12 Mar 2025 2023 FY
2021 $170,642,000 -$7,306,000 -4.1% 03 Jan 2021 01 Jan 2022 10-K 27 Feb 2024 2023 FY
2020 $177,948,000 +$27,452,000 +18% 29 Dec 2019 02 Jan 2021 10-K 28 Feb 2023 2022 FY
2019 $150,496,000 30 Dec 2018 28 Dec 2019 10-K 01 Mar 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.